Long COVID: 15 studies launched with £19.6 million government funding
July 19, 2021Sales and Marketing NHS, UK, long covid
The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …
Some under 18s to receive COVID vaccinations in the UK
July 19, 2021Sales and Marketing
Some children are to be offered COVID-19 vaccines ahead of winter in the UK. The Vaccines Minister Nadhim Zahawi told …
‘It’s Time for Trodelvy’: Charity launches petition against Gilead for drug access
July 19, 2021Sales and Marketing Cancer, Gilead, NHS, charity
The charity Breast Cancer Now has launched a petition calling on Gilead to provide free-of-charge access to its new treatment …
Pfizer to pay $345 million in EpiPen lawsuit
July 16, 2021Medical Communications Mylan, Pfizer, epipen
Pfizer has reached a $345 million settlement over consumer claims they overpaid for EpiPens as a result of unfair, anticompetitive …
Drugmakers fined a record £260 million after 10,000% drug price increase
July 16, 2021Medical Communications UK
The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma …
Younger adults with COVID still at risk of serious organ damage
July 16, 2021Medical Communications
Young adults admitted to hospital with COVID-19 are almost as likely to experience complications as those over 50, a study …
EMA validates HUTCHMED MAA for neuroendocrine tumour drug
July 16, 2021Medical Communications EU, oncology
China-based biotech HUTCHMED has announced that the EMA has validated and accepted the Marketing Authorisation Application (MAA) for surufatinib, for …
Fears for pregnant women as COVID restrictions ease
July 15, 2021COVID-19, NHS, Vaccine, maternity
The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) have expressed fears over the …
Positive data published for Jakavi in chronic GvHD
July 15, 2021Incyte and Novartis have announced the publication of positive data from Phase III trials in NEJM, demonstrating Jakavi (ruxolitinib) significantly …
New targeted lung cancer treatment coming to UK under MHRA scheme
July 15, 2021MHRA, NSCLC, UK, brexit
The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …
Lethal triple mix of winter viruses could “push NHS to breaking point”
July 15, 2021COVID-19, NHS, influenza
A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …
First ever human implant of fully artificial heart announced
July 15, 2021cardiovascular
CARMAT has announced that the first ever human implantation of their fully artificial heart, which was designed as a therapeutic …
US starts national Medicare review for Biogen’s Alzheimer’s drug
July 14, 2021Research and Development
The US government has started a review process for national Medicare coverage of Biogen’s controversial Alzheimer’s drug, Aduhelm, that was …
Study finds 40% of severe COVID infections following double jabs are immocompromised
July 14, 2021An Israeli study looking at those who have contracted COVID following double vaccination with the Pfizer jab, has found that …
AstraZeneca gets green light for £27.5bn Alexion acquisition
July 14, 2021Research and Development
AstraZeneca has been given the green light of its $39 billion buyout of US-based rare diseases business Alexion by the …
NHS: Cancer backlog to be cleared by March 2022
July 14, 2021Research and Development
NHS chiefs have announced plans to clear the backlog of cancer patients caused by the pandemic by March 2022. Due …
Half the world oblivious to link between oral hygiene and overall health
July 14, 2021Research and Development
A new study from GSK’s consumer healthcare business and Ipsos has shown that half of the world (49%) doesn’t know …
New warning added to J&J vaccine in US
July 13, 2021Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine
The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …
Scientists develop pain-free ‘holy grail’ sugar test for diabetics
July 13, 2021Manufacturing and Production
Scientists in Australia have developed a non-invasive strip that checks glucose levels through saliva that they say is the ‘holy …
Spanner in the works for Sputnik V as missing data reported
July 13, 2021Manufacturing and Production COVID-19, EMA, Russia, Vaccine
Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
